Invesco Pharmaceuticals ETF $PJP Shares Newly Bought by Outlook Wealth Advisors LLC

Outlook Wealth Advisors LLC acquired a new position in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) in the third quarter, HoldingsChannel.com reports. The institutional investor acquired 11,290 shares of the company’s stock, valued at approximately $1,392,000.

Other institutional investors have also recently made changes to their positions in the company. Lodestone Wealth Management LLC bought a new stake in Invesco Pharmaceuticals ETF during the 3rd quarter valued at approximately $25,000. Latitude Advisors LLC bought a new position in Invesco Pharmaceuticals ETF in the 3rd quarter worth approximately $29,000. Fifth Third Bancorp purchased a new stake in Invesco Pharmaceuticals ETF during the 1st quarter valued at approximately $36,000. Global Assets Advisory LLC purchased a new stake in Invesco Pharmaceuticals ETF during the 1st quarter valued at approximately $42,000. Finally, Integrated Wealth Concepts LLC bought a new stake in shares of Invesco Pharmaceuticals ETF during the second quarter valued at approximately $55,000.

Invesco Pharmaceuticals ETF Stock Performance

PJP stock opened at $130.54 on Friday. Invesco Pharmaceuticals ETF has a one year low of $95.43 and a one year high of $131.88. The company’s fifty day moving average price is $125.80 and its 200-day moving average price is $114.46. The company has a market capitalization of $579.60 million, a PE ratio of 15.59 and a beta of 0.44.

Invesco Pharmaceuticals ETF Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.